Explore 3 Stock Ideas & Industry Insights Download Free Report

800-234-336
Shopping Cart 0
countryflagNZ
Login

Agra Ventures Ltd.

Healthcare US AGFAF

0.0031USD
0.00(0%)

Last update at 2026-06-22T20:00:00Z

Day Range

0.00310.0031
LowHigh

52 Week Range

0.00110.05
LowHigh

Fundamentals

  • Previous Close 0.0031
  • Market Cap0.14M
  • Volume2
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-1.04688M
  • Revenue TTM-0.14278M
  • Revenue Per Share TTM-0.007
  • Gross Profit TTM 0.10M
  • Diluted EPS TTM-0.01

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax -0.42854M -0.58310M 14.60M -20.03060M -2.41372M
Minority interest 0.00000M 0.00000M -0.04075M 0.00000M -2.68200M
Net income -0.42854M -0.57600M 17.77M -41.93474M -5.09572M
Selling general administrative 0.45M 0.54M 0.97M 2.19M 5.06M
Selling and marketing expenses - 0.01M 0.04M - 0.00169M
Gross profit - - 0.29M 0.30M 0.38M
Reconciled depreciation - - 0.03M 0.15M 0.37M
Ebit - - -1.15300M -19.14145M -8.23571M
Ebitda -0.16499M - -1.04700M -18.99592M -7.86699M
Depreciation and amortization - 0.56M 0.11M 0.15M 0.37M
Non operating income net other - - - - -
Operating income -0.53451M -0.56203M -1.15300M -19.14145M -8.23571M
Other operating expenses 0.53M 0.56M 1.15M 20.77M 6.21M
Interest expense 0.26M 0.26M 2.64M 3.34M 6.63M
Tax provision - - - - -
Interest income - - 0.16M 0.66M 0.65M
Net interest income -0.26355M -0.25492M -2.48009M -2.68193M -5.97631M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - - 0.04M 25.54M 5.70M
Total revenue 0.00000M 0.00000M 0.57M 0.67M 0.93M
Total operating expenses 0.53M 0.56M 1.15M 20.40M 5.66M
Cost of revenue - - 0.28M 0.37M 0.55M
Total other income expense net 0.11M -0.02107M 15.76M 2.75M 8.84M
Discontinued operations - - - -21.90414M -21.90414M
Net income from continuing ops -0.42854M -0.58310M -14.83737M -20.03060M -2.41372M
Net income applicable to common shares - - - -41.93474M -41.93474M
Preferred stock and other adjustments - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 0.19M 0.29M 0.74M 1.09M 46.22M
Intangible assets - - - - 0.91M
Earning assets - - - - -
Other current assets 0.00458M - 0.00001M 0.06M 0.25M
Total liab 1.71M 1.41M 1.36M 20.03M 27.17M
Total stockholder equity -1.39129M -0.98275M -0.49046M -18.76780M 19.22M
Deferred long term liab - - - - -
Other current liab 0.50M 0.28M 0.10M 0.55M 1.00M
Common stock 204.50M 204.48M 204.39M 203.84M 199.88M
Capital stock 204.50M 204.48M 204.39M 203.84M 199.88M
Retained earnings -205.90241M -216.08400M -217.41455M -247.71072M -206.24334M
Other liab - - - - -
Good will - - - - 0.00000M
Other assets - - 0.00001M - -
Cash 0.18M 0.29M 0.74M 0.30M 3.09M
Cash and equivalents - - - - -
Total current liabilities 1.71M 1.41M 1.36M 20.03M 25.86M
Current deferred revenue - - - 0.26M 0.02M
Net debt 0.91M 0.75M 0.41M 18.23M 22.09M
Short term debt 1.10M 1.05M 1.15M 18.53M 23.88M
Short long term debt 1.10M 1.05M 1.15M 18.53M 23.78M
Short long term debt total 1.10M 1.05M 1.15M 18.53M 25.18M
Other stockholder equity 0.02M 10.63M 12.54M 25.10M -
Property plant equipment - - - - -
Total current assets 0.19M 0.29M 0.74M 1.09M 5.66M
Long term investments - - - 0.00000M 23.44M
Net tangible assets - - - -18.76780M -
Short term investments - 0.00000M 0.00045M 0.58M 1.25M
Net receivables - - - 0.08M 0.97M
Long term debt - - - - -
Inventory - - 0.00000M 0.08M 0.10M
Accounts payable 0.11M 0.08M 0.11M 0.95M 0.96M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income -0.00615M -0.00615M -0.00615M 25.10M 25.58M
Additional paid in capital - - - - -
Common stock total equity - - - - -
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - -0.00001M - 14.95M
Deferred long term asset charges - - - - -
Non current assets total 0.00000M 0.00000M -0.00001M 0.00000M 40.55M
Capital lease obligations - - 0.00000M 0.00000M 1.40M
Long term debt total - - - - -
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - 0.00000M 2.89M -1.26350M 7.84M
Change to liabilities - - - -0.25554M 0.00000M
Total cashflows from investing activities - - 3.18M -1.26350M -1.26350M
Net borrowings 0.07M -0.07000M 0.00000M - -
Total cash from financing activities 0.07M -0.07000M 0.00000M 0.38M 1.14M
Change to operating activities - - - -0.03121M -0.03121M
Net income -0.42854M -0.57626M 17.77M -41.93474M -2.41372M
Change in cash -0.11084M -0.44483M 0.43M -2.78910M 2.82M
Begin period cash flow 0.29M 0.74M 0.30M 3.09M 0.27M
End period cash flow 0.18M 0.29M 0.74M 0.30M 3.09M
Total cash from operating activities -0.18584M -0.37483M -2.74777M -23.77740M -6.21933M
Issuance of capital stock - - - - 0.00000M
Depreciation - - 0.00012M 0.15M 0.37M
Other cashflows from investing activities - - 0.23M - -
Dividends paid - - - - -
Change to inventory - 0.00000M 0.08M 0.00298M 0.01M
Change to account receivables 0.00000M 0.00684M 0.10M -0.46425M -1.98192M
Sale purchase of stock - - - - -
Other cashflows from financing activities - - 3.18M 0.38M 1.32M
Change to netincome - - - 40.64M 0.46M
Capital expenditures 0.00000M 0.00000M 0.00000M 0.00000M 0.03M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital 0.25M 0.23M -1.66966M -0.74802M -1.95342M
Stock based compensation 0.00000M 0.03M 0.04M 0.09M 0.00000M
Other non cash items -0.00597M -0.06397M -18.88799M 18.67M -2.22091M
Free cash flow -0.18584M -0.37483M -2.74777M -23.77740M -6.25072M

Peer Comparison

Sector: Healthcare Industry: Drug Manufacturers - Specialty & Generic

Company Change (USD) Price (USD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
AGFAF
Agra Ventures Ltd.		 - -% 0.0031 - - 0.22 0.04 24.45 0.08
ZTS
Zoetis Inc		 0.95 1.25% 76.84 40.18 30.96 10.67 17.60 11.27 26.18
MKKGY
Merck KGaA ADR		 0.42 1.37% 30.98 21.25 14.93 3.10 2.14 3.60 12.98
MKGAF
MERCK Kommanditgesellschaft auf Aktien		 6.43 4.31% 155.71 21.73 14.95 3.16 2.15 3.56 12.82
GALDY
GALDERMA GROUP AG		 0.48 1.12% 43.42 74.21 41.67 8.64 5.55 9.15 42.22

Reports Covered

Stock Research & News

View All

Profile

Digicann Ventures Inc. does not have significant operations. It intends to focus business opportunities to acquisitions, divestitures, joint ventures, partnerships and other such transactions or commercial arrangements within and outside of the cannabis industry. Previously, it was engaged in cannabis business. The company was formerly known as Agra Ventures Ltd. and changed its name to Digicann Ventures Inc. in August 2023. Digicann Ventures Inc. was incorporated in 2004 and is headquartered in Vancouver, Canada.

Agra Ventures Ltd.

1075 West Georgia Street, Vancouver, BC, Canada, V6E 3C9

Key Executives

Name Title Year Born
Ms. Fiona Fitzmaurice ACCA, B.A., BA, C.P.A., CGA CFO & Director NA
Ms. Elise Coppens Consultant NA
Mr. Nicholas J. Kuzyk M.B.A. Interim CEO & Director 1980
Mr. Peter Karroll Director of Branding & Marketing NA
Dr. Zbigniew Adam Szybinski M.Sc., Ph.D. VP of Exploration NA
Mr. Ruben Houweling Head of Cannabis Growing NA
Ms. Katrin Eckmans MD & CEO of Farmako GmbH NA
Mr. Nicholas J. Kuzyk M.B.A. CEO & Director 1980
Ms. Fiona Fitzmaurice ACCA, B.A., C.P.A., CGA CFO & Director 1982
Dr. Zbigniew Adam Szybinski M.Sc., Ph.D. Vice President of Exploration NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.